- Medpace Holdings ( NASDAQ: MEDP ) is projecting 2022 revenue of $1.405B-$1.435B, above the current consensus of $1.4B.
- The contract research organization is also guiding to GAAP EPS for the year of $6.07-$6.36. Consensus is $6.12.
- Medpace ( MEDP ) released its 2022 guidance as it released its Q2 results after the closing bell Monday, beating on both the top and bottom lines .
- Net income of ~$49.4M was a ~24% increased compared to Q2 2022 ($1.52 vs. $1.11 basic, and $1.46 vs. $1.06 diluted EPS).
- Q2 revenue of $351.21M was a ~26% year-over-year increase.
- Medpace ( MEDP ) noted that new business awards of $450.6M was a ~16% increase from the prior-year period.
- The company ended the quarter with $42.6M of cash and cash equivalents.
- Seeking Alpha's Quant Rating with h igh marks for profitability, momentum and revisions .
For further details see:
Medpace 2022 revenue guidance above consensus estimate as Q2 beats on top, bottom lines